TALA

Two Legend Senior Living® Directors Receive Prestigious Hero Awards From the Texas Assisted Living Association (TALA)

Retrieved on: 
Wednesday, April 3, 2024
Aircraft, Conference, Intelligence, Fichtner, TALA, ISO 9660, Legend, Nursing, Health, Human

Legend, a senior living provider based in Wichita (KS), owns and operates 55 residences in six states with eight in Texas.

Key Points: 
  • Legend, a senior living provider based in Wichita (KS), owns and operates 55 residences in six states with eight in Texas.
  • "Once you meet Haley, you quickly understand why she has been so successful in such a short period," said Samantha Jones, Regional Director of Operations, Legend Senior Living, Texas.
  • "Chris and Haley stand out in Texas's very large assisted living market, representing the best of Legend Senior Living."
  • The Texas Assisted Living Association (TALA) is "committed to enriching the lives of Texas seniors, developing those who care for them, and being a voice for both."

Foundation Medicine and Its Collaborators Announce Acceptance of 21 Abstracts at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Retrieved on: 
Friday, May 26, 2023
Research, FDA, Genetics, Biometrics, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Talazoparib, TALA, Abstract, DNA, Partnership, Circulating tumor DNA, TMB, HRR, CGP, NGS, Survival, Liquid biopsy, Booth, Lung cancer, Doctor of Philosophy, ASCO, American Society of Clinical Oncology, MD, Patient, Annual general meeting, Neoplasm, Liquid, Foundation Medicine, PBO, Society, PD-L1, Roche, Pharmaceutical industry, Medical imaging, Vaccine, Genentech

Foundation Medicine, Inc ., today announced that the company and its collaborators will present 21 abstracts demonstrating the value of high-quality tumor profiling tests to inform cancer care at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from June 2-6 in Chicago.

Key Points: 
  • Foundation Medicine, Inc ., today announced that the company and its collaborators will present 21 abstracts demonstrating the value of high-quality tumor profiling tests to inform cancer care at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from June 2-6 in Chicago.
  • Two studies being presented at ASCO further define the clinical application of ctDNA monitoring and demonstrate the value of FoundationOne®Tracker to support and inform oncologists’ treatment planning.
  • Foundation Medicine will also present new data describing FoundationOne Liquid CDx’s robust ctDNA-based detection of rearrangements and fusions.
  • Follow Foundation Medicine on Twitter and LinkedIn for more updates from #ASCO23 and visit us in person at Booth #19081.

Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual Meeting

Retrieved on: 
Thursday, May 25, 2023
Biotechnology, FDA, Other Health, Health, General Health, Pharmaceutical, Oncology, Other Science, Research, Science, Clinical Trials, Protein kinase, Safety, European Medicines Agency, PFE, Encorafenib, MEK, CDK, Acquisition, Patient, Bini, Ageing, NYSE, Priority review, Maintenance, Inc., APLS, AUC, ADP, Toxicity, Binimetinib, EMA, Doxorubicin, Medicine, Hematology, TALA, Learning, Abstract, DNA, HRR, Cancer, BRAF, NSCLC, Shanda, BSC, RRMM, PARP, PBO, Abstract (summary), B-cell maturation antigen, Woman, AVE, Clinical Genitourinary Cancer, SHP2, ASCO, American Society of Clinical Oncology, Annual general meeting, RWE, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Society, Avelumab, Food, BCMA, Breast cancer, Pharmaceutical industry, Vaccine, Seagen, Pfizer

Pfizer Inc. (NYSE: PFE) will present data across its Oncology portfolio and growing pipeline, covering multiple tumor types and novel mechanisms of action at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from June 2 through June 6.

Key Points: 
  • Pfizer Inc. (NYSE: PFE) will present data across its Oncology portfolio and growing pipeline, covering multiple tumor types and novel mechanisms of action at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from June 2 through June 6.
  • With the recently announced proposed acquisition of Seagen*, a leader in antibody-drug conjugate technology, Pfizer is further accelerating its fight against cancer to deliver the next generation of Oncology breakthroughs.
  • “Placing patients at the center of everything we do is a critical component of advancing cutting-edge science and improving outcomes for patients,” said Dany Habr, M.D., Oncology Chief Medical Affairs Officer, Pfizer.
  • **Pfizer has exclusive rights to BRAFTOVI and MEKTOVI in the U.S., Canada, and all countries in the Latin American, African, and Middle Eastern regions.

Belmont Village Senior Living’s Employees Win Texas Assisted Living Association (TALA) Hero Award

Retrieved on: 
Thursday, April 13, 2023
Commercial Building & Real Estate, Seniors, Construction & Property, Nursing, Managed Care, Health, Family, Consumer, TALA, Star, BBC Sports Unsung Hero Award, Architectural engineering, Community Care, Conference, Caregiver, Safety, Management

Belmont Village Senior Living is proud to recognize David Godden, Building Engineer at Belmont Village Lakeway, and Michael Mack, Memory Program Coordinator at Belmont Village West University, for being recipients of the prestigious Texas Assisted Living Association (TALA) Hero Award.

Key Points: 
  • Belmont Village Senior Living is proud to recognize David Godden, Building Engineer at Belmont Village Lakeway, and Michael Mack, Memory Program Coordinator at Belmont Village West University, for being recipients of the prestigious Texas Assisted Living Association (TALA) Hero Award.
  • This accolade recognizes individuals who display the highest levels of care and dedication in senior living.
  • They have proven to be an inspiration to the Belmont Village team, residents, and families,” said Belmont Village Senior Living’s Founder and CEO Patricia Will.
  • With his keen focus on safety and efficiency, Godden consistently ensures the smooth operation of all aspects of the Belmont Village Senior Living’s Lakeway community.